Investigator-Initiated Trials

NeoGenomics recognizes the important role of externally driven scientific research to expand medical knowledge and define the clinical utility of our tests in a real-world setting. The mission of the NeoGenomics Investigator-Initiated Trials (IIT) Program is to support investigator-initiated research that advances medical and scientific knowledge across the breadth of Oncology.

Areas of Interest

NeoGenomics welcomes submissions across the breadth of Oncology Research. Proposals may include retrospective testing of previously collected samples, prospective/ongoing clinical studies and NeoGenomics partnership for proposed interventional trials.

Submission Review Process and Timeline

We accept concept submissions at any time, and will review the concept and respond within one month. If a submission is of interest, a follow up request for a Full Submission will be issued.

NeoGenomics considers requests for IIT projects based on scientific merit and strategic fit with NeoGenomics’ areas of interest. We accept submissions throughout the year. On receipt of a concept, you will be contacted by one of our Medical Affairs Team to discuss the proposal as needed. If in scope, you will be invited to submit a full submission, which will be reviewed on a monthly basis following submission when a decision will be communicated. Please note that acceptance of your concept submission for a full submission does not guarantee a final approval. Submission does not imply or guarantee approval. Support is contingent upon full execution by both parties of the research agreement.

Submit a Concept Below:

By completing and submitting this form, you agree to share the information provided to NeoGenomics, and permit our team to utilize this information to contact you and further discuss your concept.